Has Marcus Stoddard, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,683 in general payments to Marcus Stoddard, MD across 26 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marcus Stoddard, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marcus Stoddard, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marcus Stoddard, MD

Cardiovascular Disease · Louisville, KYNPI 1720070196

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,119 of the $1,683 with a category attached, or 66.4%. Abbott accounts for 77.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $1,430 and has fallen 98.6% since, to $20 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in KY, where the typical reported total is $2,503.

$1,683in general payments, 2019–2025

Across 26 payments — averaging $64.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$1K
Boston Scientific$139
Siemens Medical Solutions USA, Inc.$101
E.r. Squibb & Sons, L.L.C.$39
Inari Medical, Inc.$27
Cardiovascular Systems Inc.$22
plus $57 from 4 others

$52,720in research payments, 2019–2025

Across 16 payments — averaging $3295.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Amgen$40K
Novartis$12K
Boehringer Ingelheim$398

What the payments were for

Travel & lodging$1,11966%
Food & beverage$56534%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	11	$1,299
Boston Scientific	1	$139
Siemens Medical Solutions USA, Inc.	5	$101
E.r. Squibb & Sons, L.L.C.	2	$39
Inari Medical, Inc.	1	$27
Cardiovascular Systems Inc.	2	$22
Cvrx, Inc.	1	$16
Atricure, Inc.	1	$15
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$14
Irhythm Technologies, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

WATCHMAN FLX$139

How this compares

$1,683 in reported general payments places this provider in the 40th percentile of 258 cardiovascular disease providers in Kentucky.

See all cardiovascular disease providers in Kentucky →

Medicare billing

Part B allowed, 2024

$111,861

Medicare patients

1,435

Services billed

2,997

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	45	$61,931
JardianceEmpagliflozin	22	$28,596
EntrestoSacubitril/Valsartan	14	$27,380
Metoprolol Succinate	131	$1,921
Isosorbide Mononitrate ErIsosorbide Mononitrate	42	$1,176
Rosuvastatin Calcium	45	$604
Atorvastatin Calcium	45	$574
Carvedilol	85	$522
Diltiazem 24hr ErDiltiazem Hcl	11	$487
Hydralazine Hcl	27	$383
Lisinopril	24	$304
ClopidogrelClopidogrel Bisulfate	32	$294
Warfarin Sodium	22	$225
Nitroglycerin	15	$208
Potassium Chloride	13	$200

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Louisville

Amir PirachaLouisville$530K
Dinesh KalraLouisville$316K
John HarrisLouisville$129K
Rohan SamsonLouisville$94K
Vipul PanchalLouisville$39K
Steven RaibleLouisville$30K
Chandhiran RangaswamyLouisville$19K
Joseph LashLouisville$16K
Shanker ChandiramaniLouisville$16K
Pradeep SinghLouisville$15K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →